<img src="https://ml.globenewswire.com/Resource/Download/2f22ddd0-f963-4199-b224-fbca38a7061c?size=2" nborder="0" align="left" hspace="5" vspace="5" title="PetVivo-Holdings (002) (new logo) 10-15-2025.png" alt="PetVivo Holdings, Inc."/>MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, will report financial results for the year ending March 31, 2026, on Monday, June 29, 2026 after market close. The company will host a conference call to discuss these results at 5:00 p.m. CT (6:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo’s Investor Relations website at: <a href="https://www.globenewswire.com/Tracker?data=IXcxbJJ2SzdOwfOKb60szawcQQEF0-hG2ajC1J5tkKdea5mo6o_XincXG11nPsfs8QdRyE3DSi7Vjj3I_OUWOfrkJ2J6sNtXToLWHy0M71Olo06CKNxKRJV1lcdkWqVoVZgFQMuNG3R6fSR75AsxPtjuDrw0NEMwhelhj6gS6wTiu7fPZAFhtx8mk0lQPoggSoXtrh48kchvFiZCeFaj7UqKHcPbp_I9g0W2VZ4LfF1vNvESnoOn-WTbQ6IUNY5rrfzEOVO23aYsJQRYGrB4DSfxlMTdd9u6sYU5DgjPVrc=" rel="nofollow" target="_blank" title="">https://audience.mysequire.com/webinar-view?webinar_id=da774c66-358e-4c59-ab77-3d2a687cf6fb</a> A replay of the webcast will be available through the same link following the conference call. Participants can also access the call using the dial-in details below. Date: Monday, June 29, 2026 Time: 5:00 p.m. CT (6:00 p.m. ET) Dial-in: +1 719 359 4580 Meeting ID: 82601091950 Passcode: 101283 About PetVivo Holdings, Inc. PetVivo Holdings Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiaries Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG® with OsteoCushion® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP®, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale. For more information about PetVivo Holdings, Inc. or its innovative products, Spryng and PrecisePRP, please contact <a href="https://www.globenewswire.com/Tracker?data=oS-RmugXY6NA3rYIMTVERL6y6BSJOcaVqka9c6a92c6PfxCC5Goqma494D6I653B4FnZt7rJYj8hM1YcyBzmMYEYkeLmPImdxBsZD402dRQ=" rel="nofollow" target="_blank" title="info1@petvivo.com">info1@petvivo.com</a> or visit <a href="https://www.globenewswire.com/Tracker?data=wnPIr08QOuCfQz38CPmCZ_uMdSZOyb-8B-eIiOtCk8zJulW5istrbUB4JJA0xT_gt-Cmw511iJFSH0xBmw7mIg==" rel="nofollow" target="_blank" title="petvivo.com">petvivo.com</a>, <a href="https://www.globenewswire.com/Tracker?data=wnPIr08QOuCfQz38CPmCZ_8hUAlVIoewigkCDwDJNOCg_3m4WphqogjJe1us_jAcliyKqanCUaQPXGb4Xwm2bS_f5pb05he-fXsNd6QJEQxoLKMeBY-imp_qKChGkWLJ" rel="nofollow" target="_blank" title="petvivoanimalhealth.com">petvivoanimalhealth.com</a> and <a href="https://www.globenewswire.com/Tracker?data=sW8XqoSF2Dnd4tEhZqEWtSLhcZ-n5aC5tpoOWGM8co0Qu4pPrVf-gWk12rtIrXdZZws1tO1mlbli3S3FEOxvQxekecSxvlylAwUntuomqA0=" rel="nofollow" target="_blank" title="sprynghealth.com">sprynghealth.com</a>. Company Contact John Lai, CEO PetVivo Holdings, Inc. <a href="https://www.globenewswire.com/Tracker?data=KrtviX1y_IocxiYueo1azmBdeWW55Zp6VQTvB_DrZ1PgSBNzX3jIKysQRekQS3b1wkZlew7eNb5co8xf2ZGPk2KnUERmc-J51CpD8zECbto=" rel="nofollow" target="_blank" title="Email Contact">Email Contact</a> Tel (952) 405-6216 Forward-Looking commercial Statements The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. <img alt="" src='https://ml.globenewswire.com/media/ZDNjNTcyZDYtN2U1ZC00ZDBlLThmYzktODVlMDEyNDcyZTM1LTUwMDA2ODIxMS0yMDI2LTA2LTI1LWVu/tiny/PetVivo-Holdings-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn